Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: company in trouble ripe for PTSC to purchase

Probably not with these numbers....and 103MM shares outstanding...and even though they have a large revenue base...their costs and debt is overboard.



Net Income Avl to Common (ttm): -65.84M
Diluted EPS (ttm): -0.642
Qtrly Earnings Growth (yoy): N/A
Balance Sheet
Total Cash (mrq): 49.73M
Total Cash Per Share (mrq): 0.483
Total Debt (mrq): 82.36M
4
Jan 20, 2009 10:07AM
Share
New Message
Please login to post a reply